fda compounding semaglutide crackdown september 2025 Beyond the Headlines: Warning Letters to GLP-1 Compounders The Wild East of semaglutide

"In the US, all nasal sprays or inhalation solutions are classified as drugs, which means they need to go through a New Drug Application process in order to legally be able to sell in the U.S.," says Koestline, who notes that dihydroxy methylchromonyl palmitate has not been approved for inhalation

These results are highly comparable to the efficacy of the established weekly injection

Sci 110, 52115216

Science Day has also been moved to September 4, 2024

Clinical considerations: All three products carry a boxed warning regarding the risk of thyroid C-cell tumors observed in rodent studies, contraindicating their use in patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)

Wrongful death claims arent included in the multi-district litigation (MDL)